nodes	percent_of_prediction	percent_of_DWPC	metapath
Propafenone—ADRB1—coronary artery disease	0.141	1	CbGaD
Propafenone—Quinapril—Perindopril—coronary artery disease	0.0404	0.131	CrCrCtD
Propafenone—Quinapril—Trandolapril—coronary artery disease	0.0315	0.102	CrCrCtD
Propafenone—Quinapril—Enalapril—coronary artery disease	0.0315	0.102	CrCrCtD
Propafenone—Benazepril—Trandolapril—coronary artery disease	0.03	0.0976	CrCrCtD
Propafenone—Benazepril—Enalapril—coronary artery disease	0.03	0.0976	CrCrCtD
Propafenone—Salsalate—Acetylsalicylic acid—coronary artery disease	0.0266	0.0864	CrCrCtD
Propafenone—Quinapril—Lisinopril—coronary artery disease	0.0247	0.0802	CrCrCtD
Propafenone—Quinapril—Ramipril—coronary artery disease	0.0239	0.0777	CrCrCtD
Propafenone—Benazepril—Lisinopril—coronary artery disease	0.0235	0.0764	CrCrCtD
Propafenone—ADRB1—Penbutolol—coronary artery disease	0.0232	0.0687	CbGbCtD
Propafenone—Benazepril—Ramipril—coronary artery disease	0.0228	0.074	CrCrCtD
Propafenone—Propranolol—Penbutolol—coronary artery disease	0.0227	0.0738	CrCrCtD
Propafenone—ADRB1—Timolol—coronary artery disease	0.0164	0.0484	CbGbCtD
Propafenone—CYP2C8—Fenofibrate—coronary artery disease	0.0134	0.0396	CbGbCtD
Propafenone—SCN5A—purkinje fiber—coronary artery disease	0.0127	0.269	CbGeAlD
Propafenone—CYP2C8—Gemfibrozil—coronary artery disease	0.0107	0.0316	CbGbCtD
Propafenone—ABCB1—Ticagrelor—coronary artery disease	0.0102	0.0301	CbGbCtD
Propafenone—CYP2C9—Fenofibrate—coronary artery disease	0.00933	0.0276	CbGbCtD
Propafenone—CYP2C8—Clopidogrel—coronary artery disease	0.00927	0.0274	CbGbCtD
Propafenone—CYP1A2—Gemfibrozil—coronary artery disease	0.00828	0.0245	CbGbCtD
Propafenone—CYP2C8—Pitavastatin—coronary artery disease	0.00811	0.024	CbGbCtD
Propafenone—KCNH2—purkinje fiber—coronary artery disease	0.00781	0.165	CbGeAlD
Propafenone—CYP2C9—Gemfibrozil—coronary artery disease	0.00746	0.0221	CbGbCtD
Propafenone—CYP1A2—Clopidogrel—coronary artery disease	0.00718	0.0212	CbGbCtD
Propafenone—SCN5A—endocardium—coronary artery disease	0.00655	0.138	CbGeAlD
Propafenone—CYP2C9—Clopidogrel—coronary artery disease	0.00647	0.0191	CbGbCtD
Propafenone—ABCB1—Perindopril—coronary artery disease	0.00628	0.0186	CbGbCtD
Propafenone—ABCB1—Clopidogrel—coronary artery disease	0.00628	0.0186	CbGbCtD
Propafenone—SCN5A—sinoatrial node—coronary artery disease	0.00621	0.131	CbGeAlD
Propafenone—CYP3A4—Ticagrelor—coronary artery disease	0.00609	0.018	CbGbCtD
Propafenone—CYP2C8—Acetylsalicylic acid—coronary artery disease	0.00582	0.0172	CbGbCtD
Propafenone—CYP2C9—Pitavastatin—coronary artery disease	0.00565	0.0167	CbGbCtD
Propafenone—CYP2C8—Simvastatin—coronary artery disease	0.00556	0.0164	CbGbCtD
Propafenone—CYP2C9—Valsartan—coronary artery disease	0.0055	0.0163	CbGbCtD
Propafenone—ABCB1—Telmisartan—coronary artery disease	0.00549	0.0162	CbGbCtD
Propafenone—ABCB1—Pitavastatin—coronary artery disease	0.00549	0.0162	CbGbCtD
Propafenone—CYP2C8—Lovastatin—coronary artery disease	0.00544	0.0161	CbGbCtD
Propafenone—CYP2C8—Pravastatin—coronary artery disease	0.00544	0.0161	CbGbCtD
Propafenone—CYP3A4—Fenofibrate—coronary artery disease	0.00543	0.0161	CbGbCtD
Propafenone—ABCB1—Enalapril—coronary artery disease	0.0052	0.0154	CbGbCtD
Propafenone—ABCB1—Lisinopril—coronary artery disease	0.0052	0.0154	CbGbCtD
Propafenone—CYP2C8—Atorvastatin—coronary artery disease	0.00495	0.0147	CbGbCtD
Propafenone—CYP2C8—Losartan—coronary artery disease	0.00453	0.0134	CbGbCtD
Propafenone—CYP2D6—Niacin—coronary artery disease	0.00448	0.0133	CbGbCtD
Propafenone—ABCB1—Timolol—coronary artery disease	0.00442	0.0131	CbGbCtD
Propafenone—CYP3A4—Gemfibrozil—coronary artery disease	0.00434	0.0128	CbGbCtD
Propafenone—CYP2C9—Rosuvastatin—coronary artery disease	0.00417	0.0123	CbGbCtD
Propafenone—CYP2D6—Timolol—coronary artery disease	0.00417	0.0123	CbGbCtD
Propafenone—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.00406	0.012	CbGbCtD
Propafenone—ABCB1—Ezetimibe—coronary artery disease	0.00405	0.012	CbGbCtD
Propafenone—KCNH2—endocardium—coronary artery disease	0.00403	0.0851	CbGeAlD
Propafenone—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00394	0.0117	CbGbCtD
Propafenone—ABCB1—Captopril—coronary artery disease	0.00389	0.0115	CbGbCtD
Propafenone—CYP2C9—Simvastatin—coronary artery disease	0.00388	0.0115	CbGbCtD
Propafenone—CYP2C9—Pravastatin—coronary artery disease	0.00379	0.0112	CbGbCtD
Propafenone—CYP2C9—Lovastatin—coronary artery disease	0.00379	0.0112	CbGbCtD
Propafenone—CYP3A4—Clopidogrel—coronary artery disease	0.00376	0.0111	CbGbCtD
Propafenone—ABCB1—Simvastatin—coronary artery disease	0.00376	0.0111	CbGbCtD
Propafenone—ABCB1—Lovastatin—coronary artery disease	0.00368	0.0109	CbGbCtD
Propafenone—ABCB1—Pravastatin—coronary artery disease	0.00368	0.0109	CbGbCtD
Propafenone—CYP2D6—Captopril—coronary artery disease	0.00367	0.0109	CbGbCtD
Propafenone—CYP2D6—Simvastatin—coronary artery disease	0.00354	0.0105	CbGbCtD
Propafenone—CYP1A2—Losartan—coronary artery disease	0.00351	0.0104	CbGbCtD
Propafenone—CYP3A4—Eplerenone—coronary artery disease	0.0035	0.0103	CbGbCtD
Propafenone—CYP2D6—Lovastatin—coronary artery disease	0.00347	0.0103	CbGbCtD
Propafenone—CYP2D6—Pravastatin—coronary artery disease	0.00347	0.0103	CbGbCtD
Propafenone—CYP2C9—Atorvastatin—coronary artery disease	0.00345	0.0102	CbGbCtD
Propafenone—ABCB1—Atorvastatin—coronary artery disease	0.00335	0.00992	CbGbCtD
Propafenone—CYP2C9—cardial valve—coronary artery disease	0.00327	0.0692	CbGeAlD
Propafenone—CYP2C9—Losartan—coronary artery disease	0.00316	0.00935	CbGbCtD
Propafenone—CYP2D6—Atorvastatin—coronary artery disease	0.00316	0.00934	CbGbCtD
Propafenone—CYP3A4—Enalapril—coronary artery disease	0.00312	0.00922	CbGbCtD
Propafenone—ABCB1—Losartan—coronary artery disease	0.00307	0.00907	CbGbCtD
Propafenone—CYP3A4—Ezetimibe—coronary artery disease	0.00242	0.00717	CbGbCtD
Propafenone—CYP3A4—Rosuvastatin—coronary artery disease	0.00242	0.00717	CbGbCtD
Propafenone—CYP3A4—Simvastatin—coronary artery disease	0.00225	0.00667	CbGbCtD
Propafenone—CYP3A4—Pravastatin—coronary artery disease	0.00221	0.00652	CbGbCtD
Propafenone—CYP3A4—Lovastatin—coronary artery disease	0.00221	0.00652	CbGbCtD
Propafenone—CYP3A4—Atorvastatin—coronary artery disease	0.00201	0.00594	CbGbCtD
Propafenone—CYP3A4—Losartan—coronary artery disease	0.00184	0.00543	CbGbCtD
Propafenone—SCN5A—cardiac ventricle—coronary artery disease	0.000551	0.0117	CbGeAlD
Propafenone—SCN5A—myocardium—coronary artery disease	0.000518	0.011	CbGeAlD
Propafenone—ADRB1—cardiac ventricle—coronary artery disease	0.000444	0.00938	CbGeAlD
Propafenone—ADRB1—myocardium—coronary artery disease	0.000417	0.00883	CbGeAlD
Propafenone—SCN5A—heart—coronary artery disease	0.000362	0.00765	CbGeAlD
Propafenone—SCN5A—cardiovascular system—coronary artery disease	0.000341	0.00722	CbGeAlD
Propafenone—KCNH2—cardiac ventricle—coronary artery disease	0.000339	0.00717	CbGeAlD
Propafenone—KCNH2—myocardium—coronary artery disease	0.000319	0.00674	CbGeAlD
Propafenone—SCN5A—cardiac atrium—coronary artery disease	0.000309	0.00654	CbGeAlD
Propafenone—ADRB1—heart—coronary artery disease	0.000291	0.00616	CbGeAlD
Propafenone—ADRB1—cardiovascular system—coronary artery disease	0.000275	0.00581	CbGeAlD
Propafenone—SCN5A—blood—coronary artery disease	0.00027	0.00571	CbGeAlD
Propafenone—ADRB1—cardiac atrium—coronary artery disease	0.000249	0.00527	CbGeAlD
Propafenone—Carvedilol—NPPB—coronary artery disease	0.000241	0.0833	CrCbGaD
Propafenone—Carvedilol—GJA1—coronary artery disease	0.000241	0.0833	CrCbGaD
Propafenone—Carvedilol—SELE—coronary artery disease	0.000228	0.079	CrCbGaD
Propafenone—KCNH2—heart—coronary artery disease	0.000222	0.0047	CbGeAlD
Propafenone—Carvedilol—VCAM1—coronary artery disease	0.000218	0.0753	CrCbGaD
Propafenone—KCNH2—cardiovascular system—coronary artery disease	0.00021	0.00444	CbGeAlD
Propafenone—KCNH2—cardiac atrium—coronary artery disease	0.00019	0.00402	CbGeAlD
Propafenone—Carvedilol—HIF1A—coronary artery disease	0.000183	0.0631	CrCbGaD
Propafenone—CYP2C9—heart—coronary artery disease	0.000181	0.00382	CbGeAlD
Propafenone—CYP2C9—cardiovascular system—coronary artery disease	0.000171	0.00361	CbGeAlD
Propafenone—KCNH2—blood—coronary artery disease	0.000166	0.00351	CbGeAlD
Propafenone—CYP2C8—blood—coronary artery disease	0.000152	0.00321	CbGeAlD
Propafenone—CYP1A2—blood—coronary artery disease	0.000142	0.00301	CbGeAlD
Propafenone—CYP2C9—blood—coronary artery disease	0.000135	0.00285	CbGeAlD
Propafenone—Esmolol—ADRB1—coronary artery disease	0.000109	0.0377	CrCbGaD
Propafenone—Bevantolol—ADRB1—coronary artery disease	0.000108	0.0373	CrCbGaD
Propafenone—CYP3A4—blood—coronary artery disease	0.000103	0.00218	CbGeAlD
Propafenone—CYP2D6—blood—coronary artery disease	0.000101	0.00214	CbGeAlD
Propafenone—Bopindolol—ADRB1—coronary artery disease	9.98e-05	0.0345	CrCbGaD
Propafenone—ABCB1—heart—coronary artery disease	9.76e-05	0.00206	CbGeAlD
Propafenone—Benazepril—MTHFR—coronary artery disease	9.71e-05	0.0336	CrCbGaD
Propafenone—Salmeterol—ADRB2—coronary artery disease	9.42e-05	0.0326	CrCbGaD
Propafenone—ABCB1—cardiovascular system—coronary artery disease	9.21e-05	0.00195	CbGeAlD
Propafenone—Esmolol—ADRB2—coronary artery disease	9.18e-05	0.0317	CrCbGaD
Propafenone—Quinapril—ACE—coronary artery disease	9.1e-05	0.0314	CrCbGaD
Propafenone—Bevantolol—ADRB2—coronary artery disease	9.07e-05	0.0313	CrCbGaD
Propafenone—Bopindolol—ADRB2—coronary artery disease	8.39e-05	0.029	CrCbGaD
Propafenone—Dextropropoxyphene—OPRD1—coronary artery disease	8.21e-05	0.0284	CrCbGaD
Propafenone—Fentanyl—OPRD1—coronary artery disease	8.12e-05	0.0281	CrCbGaD
Propafenone—Benazepril—ACE—coronary artery disease	7.91e-05	0.0274	CrCbGaD
Propafenone—Carvedilol—VEGFA—coronary artery disease	7.36e-05	0.0254	CrCbGaD
Propafenone—ABCB1—blood—coronary artery disease	7.28e-05	0.00154	CbGeAlD
Propafenone—Labetalol—ADRB1—coronary artery disease	7.15e-05	0.0247	CrCbGaD
Propafenone—Phenoxybenzamine—SLC22A3—coronary artery disease	6.98e-05	0.0241	CrCbGaD
Propafenone—Labetalol—ADRB2—coronary artery disease	6.02e-05	0.0208	CrCbGaD
Propafenone—Carvedilol—ADRB1—coronary artery disease	4.92e-05	0.017	CrCbGaD
Propafenone—Mirabegron—ALB—coronary artery disease	4.92e-05	0.017	CrCbGaD
Propafenone—Carvedilol—ADRB2—coronary artery disease	4.14e-05	0.0143	CrCbGaD
Propafenone—Oxaprozin—PTGS2—coronary artery disease	3.99e-05	0.0138	CrCbGaD
Propafenone—Salsalate—PTGS2—coronary artery disease	3.99e-05	0.0138	CrCbGaD
Propafenone—Propranolol—ADRB1—coronary artery disease	3.74e-05	0.0129	CrCbGaD
Propafenone—Phenoxybenzamine—ADRB2—coronary artery disease	3.19e-05	0.011	CrCbGaD
Propafenone—Propranolol—ADRB2—coronary artery disease	3.15e-05	0.0109	CrCbGaD
Propafenone—Atomoxetine—CYP2C19—coronary artery disease	2.85e-05	0.00987	CrCbGaD
Propafenone—Propranolol—CYP2C19—coronary artery disease	2.71e-05	0.00937	CrCbGaD
Propafenone—Atomoxetine—HTR2A—coronary artery disease	2.31e-05	0.008	CrCbGaD
Propafenone—Discomfort—Timolol—coronary artery disease	2.23e-05	0.000178	CcSEcCtD
Propafenone—Asthenia—Niacin—coronary artery disease	2.22e-05	0.000178	CcSEcCtD
Propafenone—Fatigue—Losartan—coronary artery disease	2.22e-05	0.000178	CcSEcCtD
Propafenone—Headache—Ezetimibe—coronary artery disease	2.22e-05	0.000177	CcSEcCtD
Propafenone—Malaise—Lisinopril—coronary artery disease	2.21e-05	0.000177	CcSEcCtD
Propafenone—Oedema—Ramipril—coronary artery disease	2.21e-05	0.000177	CcSEcCtD
Propafenone—Vertigo—Lisinopril—coronary artery disease	2.21e-05	0.000177	CcSEcCtD
Propafenone—Dry mouth—Timolol—coronary artery disease	2.2e-05	0.000176	CcSEcCtD
Propafenone—Pain—Losartan—coronary artery disease	2.2e-05	0.000176	CcSEcCtD
Propafenone—Constipation—Losartan—coronary artery disease	2.2e-05	0.000176	CcSEcCtD
Propafenone—Syncope—Lisinopril—coronary artery disease	2.2e-05	0.000176	CcSEcCtD
Propafenone—Vomiting—Eplerenone—coronary artery disease	2.2e-05	0.000176	CcSEcCtD
Propafenone—Feeling abnormal—Furosemide—coronary artery disease	2.2e-05	0.000176	CcSEcCtD
Propafenone—Leukopenia—Lisinopril—coronary artery disease	2.2e-05	0.000176	CcSEcCtD
Propafenone—Nausea—Fenofibrate—coronary artery disease	2.19e-05	0.000176	CcSEcCtD
Propafenone—Pruritus—Niacin—coronary artery disease	2.19e-05	0.000175	CcSEcCtD
Propafenone—Asthenia—Pravastatin—coronary artery disease	2.19e-05	0.000175	CcSEcCtD
Propafenone—Gastrointestinal pain—Furosemide—coronary artery disease	2.18e-05	0.000175	CcSEcCtD
Propafenone—Rash—Eplerenone—coronary artery disease	2.18e-05	0.000175	CcSEcCtD
Propafenone—Urticaria—Perindopril—coronary artery disease	2.18e-05	0.000175	CcSEcCtD
Propafenone—Hypersensitivity—Trandolapril—coronary artery disease	2.18e-05	0.000175	CcSEcCtD
Propafenone—Dermatitis—Eplerenone—coronary artery disease	2.18e-05	0.000175	CcSEcCtD
Propafenone—Diarrhoea—Valsartan—coronary artery disease	2.18e-05	0.000174	CcSEcCtD
Propafenone—Confusional state—Timolol—coronary artery disease	2.18e-05	0.000174	CcSEcCtD
Propafenone—Shock—Ramipril—coronary artery disease	2.17e-05	0.000174	CcSEcCtD
Propafenone—Hypersensitivity—Enalapril—coronary artery disease	2.17e-05	0.000174	CcSEcCtD
Propafenone—Abdominal pain—Perindopril—coronary artery disease	2.17e-05	0.000174	CcSEcCtD
Propafenone—Body temperature increased—Perindopril—coronary artery disease	2.17e-05	0.000174	CcSEcCtD
Propafenone—Palpitations—Lisinopril—coronary artery disease	2.17e-05	0.000174	CcSEcCtD
Propafenone—Diarrhoea—Olmesartan—coronary artery disease	2.17e-05	0.000174	CcSEcCtD
Propafenone—Headache—Eplerenone—coronary artery disease	2.17e-05	0.000174	CcSEcCtD
Propafenone—Nervous system disorder—Ramipril—coronary artery disease	2.17e-05	0.000173	CcSEcCtD
Propafenone—Thrombocytopenia—Ramipril—coronary artery disease	2.16e-05	0.000173	CcSEcCtD
Propafenone—Oedema—Timolol—coronary artery disease	2.16e-05	0.000173	CcSEcCtD
Propafenone—Pruritus—Pravastatin—coronary artery disease	2.16e-05	0.000173	CcSEcCtD
Propafenone—Loss of consciousness—Lisinopril—coronary artery disease	2.16e-05	0.000173	CcSEcCtD
Propafenone—Nausea—Clopidogrel—coronary artery disease	2.16e-05	0.000173	CcSEcCtD
Propafenone—Tachycardia—Ramipril—coronary artery disease	2.16e-05	0.000173	CcSEcCtD
Propafenone—Skin disorder—Ramipril—coronary artery disease	2.15e-05	0.000172	CcSEcCtD
Propafenone—Infection—Timolol—coronary artery disease	2.15e-05	0.000172	CcSEcCtD
Propafenone—Vomiting—Simvastatin—coronary artery disease	2.14e-05	0.000172	CcSEcCtD
Propafenone—Hypersensitivity—Telmisartan—coronary artery disease	2.14e-05	0.000172	CcSEcCtD
Propafenone—Cough—Lisinopril—coronary artery disease	2.14e-05	0.000171	CcSEcCtD
Propafenone—Nausea—Lovastatin—coronary artery disease	2.14e-05	0.000171	CcSEcCtD
Propafenone—Hyperhidrosis—Ramipril—coronary artery disease	2.14e-05	0.000171	CcSEcCtD
Propafenone—Rash—Simvastatin—coronary artery disease	2.13e-05	0.00017	CcSEcCtD
Propafenone—Dermatitis—Simvastatin—coronary artery disease	2.12e-05	0.00017	CcSEcCtD
Propafenone—Asthenia—Trandolapril—coronary artery disease	2.12e-05	0.00017	CcSEcCtD
Propafenone—Shock—Timolol—coronary artery disease	2.12e-05	0.00017	CcSEcCtD
Propafenone—Feeling abnormal—Losartan—coronary artery disease	2.12e-05	0.00017	CcSEcCtD
Propafenone—Urticaria—Furosemide—coronary artery disease	2.12e-05	0.00017	CcSEcCtD
Propafenone—Diarrhoea—Niacin—coronary artery disease	2.12e-05	0.00017	CcSEcCtD
Propafenone—Nervous system disorder—Timolol—coronary artery disease	2.12e-05	0.00017	CcSEcCtD
Propafenone—Asthenia—Enalapril—coronary artery disease	2.12e-05	0.000169	CcSEcCtD
Propafenone—Headache—Simvastatin—coronary artery disease	2.11e-05	0.000169	CcSEcCtD
Propafenone—Body temperature increased—Furosemide—coronary artery disease	2.11e-05	0.000169	CcSEcCtD
Propafenone—Abdominal pain—Furosemide—coronary artery disease	2.11e-05	0.000169	CcSEcCtD
Propafenone—Gastrointestinal pain—Losartan—coronary artery disease	2.11e-05	0.000169	CcSEcCtD
Propafenone—Dizziness—Valsartan—coronary artery disease	2.11e-05	0.000169	CcSEcCtD
Propafenone—Anorexia—Ramipril—coronary artery disease	2.11e-05	0.000169	CcSEcCtD
Propafenone—Nausea—Ezetimibe—coronary artery disease	2.1e-05	0.000168	CcSEcCtD
Propafenone—Skin disorder—Timolol—coronary artery disease	2.1e-05	0.000168	CcSEcCtD
Propafenone—Dizziness—Olmesartan—coronary artery disease	2.1e-05	0.000168	CcSEcCtD
Propafenone—Pruritus—Trandolapril—coronary artery disease	2.09e-05	0.000168	CcSEcCtD
Propafenone—Chest pain—Lisinopril—coronary artery disease	2.09e-05	0.000167	CcSEcCtD
Propafenone—Myalgia—Lisinopril—coronary artery disease	2.09e-05	0.000167	CcSEcCtD
Propafenone—Hyperhidrosis—Timolol—coronary artery disease	2.09e-05	0.000167	CcSEcCtD
Propafenone—Asthenia—Telmisartan—coronary artery disease	2.09e-05	0.000167	CcSEcCtD
Propafenone—Pruritus—Enalapril—coronary artery disease	2.09e-05	0.000167	CcSEcCtD
Propafenone—Diarrhoea—Pravastatin—coronary artery disease	2.09e-05	0.000167	CcSEcCtD
Propafenone—Anxiety—Lisinopril—coronary artery disease	2.08e-05	0.000167	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	2.08e-05	0.000166	CcSEcCtD
Propafenone—Discomfort—Lisinopril—coronary artery disease	2.06e-05	0.000165	CcSEcCtD
Propafenone—Hypotension—Ramipril—coronary artery disease	2.06e-05	0.000165	CcSEcCtD
Propafenone—Anorexia—Timolol—coronary artery disease	2.06e-05	0.000165	CcSEcCtD
Propafenone—Pruritus—Telmisartan—coronary artery disease	2.06e-05	0.000165	CcSEcCtD
Propafenone—Nausea—Eplerenone—coronary artery disease	2.06e-05	0.000165	CcSEcCtD
Propafenone—Dizziness—Niacin—coronary artery disease	2.05e-05	0.000164	CcSEcCtD
Propafenone—Urticaria—Losartan—coronary artery disease	2.05e-05	0.000164	CcSEcCtD
Propafenone—Dry mouth—Lisinopril—coronary artery disease	2.04e-05	0.000164	CcSEcCtD
Propafenone—Abdominal pain—Losartan—coronary artery disease	2.04e-05	0.000163	CcSEcCtD
Propafenone—Body temperature increased—Losartan—coronary artery disease	2.04e-05	0.000163	CcSEcCtD
Propafenone—Asthenia—Captopril—coronary artery disease	2.03e-05	0.000162	CcSEcCtD
Propafenone—Diarrhoea—Trandolapril—coronary artery disease	2.03e-05	0.000162	CcSEcCtD
Propafenone—Vomiting—Valsartan—coronary artery disease	2.03e-05	0.000162	CcSEcCtD
Propafenone—Confusional state—Lisinopril—coronary artery disease	2.02e-05	0.000162	CcSEcCtD
Propafenone—Diarrhoea—Enalapril—coronary artery disease	2.02e-05	0.000162	CcSEcCtD
Propafenone—Hypotension—Timolol—coronary artery disease	2.02e-05	0.000162	CcSEcCtD
Propafenone—Dizziness—Pravastatin—coronary artery disease	2.02e-05	0.000161	CcSEcCtD
Propafenone—Vomiting—Olmesartan—coronary artery disease	2.02e-05	0.000161	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Ramipril—coronary artery disease	2.01e-05	0.000161	CcSEcCtD
Propafenone—Rash—Valsartan—coronary artery disease	2.01e-05	0.000161	CcSEcCtD
Propafenone—Dermatitis—Valsartan—coronary artery disease	2.01e-05	0.000161	CcSEcCtD
Propafenone—Nausea—Simvastatin—coronary artery disease	2e-05	0.00016	CcSEcCtD
Propafenone—Oedema—Lisinopril—coronary artery disease	2e-05	0.00016	CcSEcCtD
Propafenone—Pruritus—Captopril—coronary artery disease	2e-05	0.00016	CcSEcCtD
Propafenone—Rash—Olmesartan—coronary artery disease	2e-05	0.00016	CcSEcCtD
Propafenone—Insomnia—Ramipril—coronary artery disease	2e-05	0.00016	CcSEcCtD
Propafenone—Dermatitis—Olmesartan—coronary artery disease	2e-05	0.00016	CcSEcCtD
Propafenone—Headache—Valsartan—coronary artery disease	2e-05	0.00016	CcSEcCtD
Propafenone—Diarrhoea—Telmisartan—coronary artery disease	1.99e-05	0.000159	CcSEcCtD
Propafenone—Infection—Lisinopril—coronary artery disease	1.99e-05	0.000159	CcSEcCtD
Propafenone—Headache—Olmesartan—coronary artery disease	1.99e-05	0.000159	CcSEcCtD
Propafenone—Paraesthesia—Ramipril—coronary artery disease	1.98e-05	0.000159	CcSEcCtD
Propafenone—Shock—Lisinopril—coronary artery disease	1.97e-05	0.000158	CcSEcCtD
Propafenone—Asthenia—Perindopril—coronary artery disease	1.97e-05	0.000158	CcSEcCtD
Propafenone—Dyspnoea—Ramipril—coronary artery disease	1.97e-05	0.000158	CcSEcCtD
Propafenone—Vomiting—Niacin—coronary artery disease	1.97e-05	0.000158	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Timolol—coronary artery disease	1.97e-05	0.000157	CcSEcCtD
Propafenone—Hypersensitivity—Furosemide—coronary artery disease	1.97e-05	0.000157	CcSEcCtD
Propafenone—Somnolence—Ramipril—coronary artery disease	1.96e-05	0.000157	CcSEcCtD
Propafenone—Thrombocytopenia—Lisinopril—coronary artery disease	1.96e-05	0.000157	CcSEcCtD
Propafenone—Dizziness—Trandolapril—coronary artery disease	1.96e-05	0.000157	CcSEcCtD
Propafenone—Tachycardia—Lisinopril—coronary artery disease	1.96e-05	0.000156	CcSEcCtD
Propafenone—Insomnia—Timolol—coronary artery disease	1.95e-05	0.000156	CcSEcCtD
Propafenone—Rash—Niacin—coronary artery disease	1.95e-05	0.000156	CcSEcCtD
Propafenone—Dermatitis—Niacin—coronary artery disease	1.95e-05	0.000156	CcSEcCtD
Propafenone—Dizziness—Enalapril—coronary artery disease	1.95e-05	0.000156	CcSEcCtD
Propafenone—Skin disorder—Lisinopril—coronary artery disease	1.95e-05	0.000156	CcSEcCtD
Propafenone—Dyspepsia—Ramipril—coronary artery disease	1.94e-05	0.000156	CcSEcCtD
Propafenone—Pruritus—Perindopril—coronary artery disease	1.94e-05	0.000156	CcSEcCtD
Propafenone—Headache—Niacin—coronary artery disease	1.94e-05	0.000155	CcSEcCtD
Propafenone—Paraesthesia—Timolol—coronary artery disease	1.94e-05	0.000155	CcSEcCtD
Propafenone—Vomiting—Pravastatin—coronary artery disease	1.94e-05	0.000155	CcSEcCtD
Propafenone—Hyperhidrosis—Lisinopril—coronary artery disease	1.94e-05	0.000155	CcSEcCtD
Propafenone—Diarrhoea—Captopril—coronary artery disease	1.94e-05	0.000155	CcSEcCtD
Propafenone—Dyspnoea—Timolol—coronary artery disease	1.93e-05	0.000154	CcSEcCtD
Propafenone—Dizziness—Telmisartan—coronary artery disease	1.92e-05	0.000154	CcSEcCtD
Propafenone—Rash—Pravastatin—coronary artery disease	1.92e-05	0.000154	CcSEcCtD
Propafenone—Dermatitis—Pravastatin—coronary artery disease	1.92e-05	0.000154	CcSEcCtD
Propafenone—Decreased appetite—Ramipril—coronary artery disease	1.92e-05	0.000154	CcSEcCtD
Propafenone—Somnolence—Timolol—coronary artery disease	1.92e-05	0.000154	CcSEcCtD
Propafenone—Asthenia—Furosemide—coronary artery disease	1.92e-05	0.000153	CcSEcCtD
Propafenone—Headache—Pravastatin—coronary artery disease	1.91e-05	0.000153	CcSEcCtD
Propafenone—Anorexia—Lisinopril—coronary artery disease	1.91e-05	0.000153	CcSEcCtD
Propafenone—Gastrointestinal disorder—Ramipril—coronary artery disease	1.91e-05	0.000153	CcSEcCtD
Propafenone—Fatigue—Ramipril—coronary artery disease	1.9e-05	0.000152	CcSEcCtD
Propafenone—Dyspepsia—Timolol—coronary artery disease	1.9e-05	0.000152	CcSEcCtD
Propafenone—Hypersensitivity—Losartan—coronary artery disease	1.9e-05	0.000152	CcSEcCtD
Propafenone—Nausea—Valsartan—coronary artery disease	1.89e-05	0.000151	CcSEcCtD
Propafenone—Pruritus—Furosemide—coronary artery disease	1.89e-05	0.000151	CcSEcCtD
Propafenone—Constipation—Ramipril—coronary artery disease	1.89e-05	0.000151	CcSEcCtD
Propafenone—Nausea—Olmesartan—coronary artery disease	1.88e-05	0.000151	CcSEcCtD
Propafenone—Vomiting—Trandolapril—coronary artery disease	1.88e-05	0.000151	CcSEcCtD
Propafenone—Diarrhoea—Perindopril—coronary artery disease	1.88e-05	0.00015	CcSEcCtD
Propafenone—Decreased appetite—Timolol—coronary artery disease	1.88e-05	0.00015	CcSEcCtD
Propafenone—Vomiting—Enalapril—coronary artery disease	1.88e-05	0.00015	CcSEcCtD
Propafenone—Hypotension—Lisinopril—coronary artery disease	1.87e-05	0.00015	CcSEcCtD
Propafenone—Dizziness—Captopril—coronary artery disease	1.87e-05	0.00015	CcSEcCtD
Propafenone—Rash—Trandolapril—coronary artery disease	1.87e-05	0.000149	CcSEcCtD
Propafenone—Dermatitis—Trandolapril—coronary artery disease	1.87e-05	0.000149	CcSEcCtD
Propafenone—Gastrointestinal disorder—Timolol—coronary artery disease	1.86e-05	0.000149	CcSEcCtD
Propafenone—Fatigue—Timolol—coronary artery disease	1.86e-05	0.000149	CcSEcCtD
Propafenone—Rash—Enalapril—coronary artery disease	1.86e-05	0.000149	CcSEcCtD
Propafenone—Dermatitis—Enalapril—coronary artery disease	1.86e-05	0.000149	CcSEcCtD
Propafenone—Headache—Trandolapril—coronary artery disease	1.86e-05	0.000148	CcSEcCtD
Propafenone—Vomiting—Telmisartan—coronary artery disease	1.85e-05	0.000148	CcSEcCtD
Propafenone—Asthenia—Losartan—coronary artery disease	1.85e-05	0.000148	CcSEcCtD
Propafenone—Headache—Enalapril—coronary artery disease	1.85e-05	0.000148	CcSEcCtD
Propafenone—Pain—Timolol—coronary artery disease	1.85e-05	0.000148	CcSEcCtD
Propafenone—Nausea—Niacin—coronary artery disease	1.84e-05	0.000147	CcSEcCtD
Propafenone—Rash—Telmisartan—coronary artery disease	1.83e-05	0.000147	CcSEcCtD
Propafenone—Dermatitis—Telmisartan—coronary artery disease	1.83e-05	0.000147	CcSEcCtD
Propafenone—Diarrhoea—Furosemide—coronary artery disease	1.83e-05	0.000146	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Lisinopril—coronary artery disease	1.83e-05	0.000146	CcSEcCtD
Propafenone—Pruritus—Losartan—coronary artery disease	1.82e-05	0.000146	CcSEcCtD
Propafenone—Headache—Telmisartan—coronary artery disease	1.82e-05	0.000146	CcSEcCtD
Propafenone—Feeling abnormal—Ramipril—coronary artery disease	1.82e-05	0.000146	CcSEcCtD
Propafenone—Dizziness—Perindopril—coronary artery disease	1.82e-05	0.000145	CcSEcCtD
Propafenone—Insomnia—Lisinopril—coronary artery disease	1.81e-05	0.000145	CcSEcCtD
Propafenone—Nausea—Pravastatin—coronary artery disease	1.81e-05	0.000145	CcSEcCtD
Propafenone—Gastrointestinal pain—Ramipril—coronary artery disease	1.81e-05	0.000145	CcSEcCtD
Propafenone—Paraesthesia—Lisinopril—coronary artery disease	1.8e-05	0.000144	CcSEcCtD
Propafenone—Vomiting—Captopril—coronary artery disease	1.8e-05	0.000144	CcSEcCtD
Propafenone—Dyspnoea—Lisinopril—coronary artery disease	1.79e-05	0.000143	CcSEcCtD
Propafenone—Rash—Captopril—coronary artery disease	1.78e-05	0.000143	CcSEcCtD
Propafenone—Dermatitis—Captopril—coronary artery disease	1.78e-05	0.000143	CcSEcCtD
Propafenone—Somnolence—Lisinopril—coronary artery disease	1.78e-05	0.000143	CcSEcCtD
Propafenone—Feeling abnormal—Timolol—coronary artery disease	1.78e-05	0.000142	CcSEcCtD
Propafenone—Headache—Captopril—coronary artery disease	1.77e-05	0.000142	CcSEcCtD
Propafenone—Gastrointestinal pain—Timolol—coronary artery disease	1.77e-05	0.000141	CcSEcCtD
Propafenone—Dizziness—Furosemide—coronary artery disease	1.77e-05	0.000141	CcSEcCtD
Propafenone—Dyspepsia—Lisinopril—coronary artery disease	1.76e-05	0.000141	CcSEcCtD
Propafenone—Diarrhoea—Losartan—coronary artery disease	1.76e-05	0.000141	CcSEcCtD
Propafenone—Nausea—Trandolapril—coronary artery disease	1.76e-05	0.000141	CcSEcCtD
Propafenone—Urticaria—Ramipril—coronary artery disease	1.75e-05	0.00014	CcSEcCtD
Propafenone—Nausea—Enalapril—coronary artery disease	1.75e-05	0.00014	CcSEcCtD
Propafenone—Vomiting—Perindopril—coronary artery disease	1.75e-05	0.00014	CcSEcCtD
Propafenone—Abdominal pain—Ramipril—coronary artery disease	1.75e-05	0.00014	CcSEcCtD
Propafenone—Body temperature increased—Ramipril—coronary artery disease	1.75e-05	0.00014	CcSEcCtD
Propafenone—Decreased appetite—Lisinopril—coronary artery disease	1.74e-05	0.000139	CcSEcCtD
Propafenone—Rash—Perindopril—coronary artery disease	1.73e-05	0.000139	CcSEcCtD
Propafenone—Dermatitis—Perindopril—coronary artery disease	1.73e-05	0.000138	CcSEcCtD
Propafenone—Gastrointestinal disorder—Lisinopril—coronary artery disease	1.73e-05	0.000138	CcSEcCtD
Propafenone—Nausea—Telmisartan—coronary artery disease	1.73e-05	0.000138	CcSEcCtD
Propafenone—Fatigue—Lisinopril—coronary artery disease	1.73e-05	0.000138	CcSEcCtD
Propafenone—Headache—Perindopril—coronary artery disease	1.72e-05	0.000138	CcSEcCtD
Propafenone—Urticaria—Timolol—coronary artery disease	1.72e-05	0.000137	CcSEcCtD
Propafenone—Pain—Lisinopril—coronary artery disease	1.71e-05	0.000137	CcSEcCtD
Propafenone—Constipation—Lisinopril—coronary artery disease	1.71e-05	0.000137	CcSEcCtD
Propafenone—Body temperature increased—Timolol—coronary artery disease	1.71e-05	0.000137	CcSEcCtD
Propafenone—Abdominal pain—Timolol—coronary artery disease	1.71e-05	0.000137	CcSEcCtD
Propafenone—Dizziness—Losartan—coronary artery disease	1.7e-05	0.000136	CcSEcCtD
Propafenone—Vomiting—Furosemide—coronary artery disease	1.7e-05	0.000136	CcSEcCtD
Propafenone—Rash—Furosemide—coronary artery disease	1.68e-05	0.000135	CcSEcCtD
Propafenone—Dermatitis—Furosemide—coronary artery disease	1.68e-05	0.000135	CcSEcCtD
Propafenone—Nausea—Captopril—coronary artery disease	1.68e-05	0.000134	CcSEcCtD
Propafenone—Headache—Furosemide—coronary artery disease	1.67e-05	0.000134	CcSEcCtD
Propafenone—Feeling abnormal—Lisinopril—coronary artery disease	1.65e-05	0.000132	CcSEcCtD
Propafenone—Gastrointestinal pain—Lisinopril—coronary artery disease	1.64e-05	0.000131	CcSEcCtD
Propafenone—Vomiting—Losartan—coronary artery disease	1.64e-05	0.000131	CcSEcCtD
Propafenone—Nausea—Perindopril—coronary artery disease	1.63e-05	0.000131	CcSEcCtD
Propafenone—Hypersensitivity—Ramipril—coronary artery disease	1.63e-05	0.00013	CcSEcCtD
Propafenone—Rash—Losartan—coronary artery disease	1.62e-05	0.00013	CcSEcCtD
Propafenone—Dermatitis—Losartan—coronary artery disease	1.62e-05	0.00013	CcSEcCtD
Propafenone—Headache—Losartan—coronary artery disease	1.61e-05	0.000129	CcSEcCtD
Propafenone—Urticaria—Lisinopril—coronary artery disease	1.59e-05	0.000127	CcSEcCtD
Propafenone—Hypersensitivity—Timolol—coronary artery disease	1.59e-05	0.000127	CcSEcCtD
Propafenone—Nausea—Furosemide—coronary artery disease	1.59e-05	0.000127	CcSEcCtD
Propafenone—Asthenia—Ramipril—coronary artery disease	1.58e-05	0.000127	CcSEcCtD
Propafenone—Abdominal pain—Lisinopril—coronary artery disease	1.58e-05	0.000127	CcSEcCtD
Propafenone—Body temperature increased—Lisinopril—coronary artery disease	1.58e-05	0.000127	CcSEcCtD
Propafenone—Pruritus—Ramipril—coronary artery disease	1.56e-05	0.000125	CcSEcCtD
Propafenone—Asthenia—Timolol—coronary artery disease	1.55e-05	0.000124	CcSEcCtD
Propafenone—Nausea—Losartan—coronary artery disease	1.53e-05	0.000122	CcSEcCtD
Propafenone—Pruritus—Timolol—coronary artery disease	1.53e-05	0.000122	CcSEcCtD
Propafenone—Diarrhoea—Ramipril—coronary artery disease	1.51e-05	0.000121	CcSEcCtD
Propafenone—Diarrhoea—Timolol—coronary artery disease	1.48e-05	0.000118	CcSEcCtD
Propafenone—Hypersensitivity—Lisinopril—coronary artery disease	1.48e-05	0.000118	CcSEcCtD
Propafenone—Dizziness—Ramipril—coronary artery disease	1.46e-05	0.000117	CcSEcCtD
Propafenone—Asthenia—Lisinopril—coronary artery disease	1.44e-05	0.000115	CcSEcCtD
Propafenone—Dizziness—Timolol—coronary artery disease	1.43e-05	0.000114	CcSEcCtD
Propafenone—Pruritus—Lisinopril—coronary artery disease	1.42e-05	0.000113	CcSEcCtD
Propafenone—Vomiting—Ramipril—coronary artery disease	1.4e-05	0.000112	CcSEcCtD
Propafenone—Rash—Ramipril—coronary artery disease	1.39e-05	0.000111	CcSEcCtD
Propafenone—Dermatitis—Ramipril—coronary artery disease	1.39e-05	0.000111	CcSEcCtD
Propafenone—Headache—Ramipril—coronary artery disease	1.38e-05	0.000111	CcSEcCtD
Propafenone—Vomiting—Timolol—coronary artery disease	1.37e-05	0.00011	CcSEcCtD
Propafenone—Diarrhoea—Lisinopril—coronary artery disease	1.37e-05	0.00011	CcSEcCtD
Propafenone—Rash—Timolol—coronary artery disease	1.36e-05	0.000109	CcSEcCtD
Propafenone—Dermatitis—Timolol—coronary artery disease	1.36e-05	0.000109	CcSEcCtD
Propafenone—Headache—Timolol—coronary artery disease	1.35e-05	0.000108	CcSEcCtD
Propafenone—Dizziness—Lisinopril—coronary artery disease	1.32e-05	0.000106	CcSEcCtD
Propafenone—Nausea—Ramipril—coronary artery disease	1.31e-05	0.000105	CcSEcCtD
Propafenone—Nausea—Timolol—coronary artery disease	1.28e-05	0.000103	CcSEcCtD
Propafenone—Vomiting—Lisinopril—coronary artery disease	1.27e-05	0.000102	CcSEcCtD
Propafenone—Rash—Lisinopril—coronary artery disease	1.26e-05	0.000101	CcSEcCtD
Propafenone—Dermatitis—Lisinopril—coronary artery disease	1.26e-05	0.000101	CcSEcCtD
Propafenone—Headache—Lisinopril—coronary artery disease	1.25e-05	0.0001	CcSEcCtD
Propafenone—Nausea—Lisinopril—coronary artery disease	1.19e-05	9.52e-05	CcSEcCtD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	2.58e-06	6.77e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—AGT—coronary artery disease	2.58e-06	6.77e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CTGF—coronary artery disease	2.55e-06	6.69e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—LEP—coronary artery disease	2.52e-06	6.63e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—APOE—coronary artery disease	2.52e-06	6.63e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CTGF—coronary artery disease	2.52e-06	6.63e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—HMGCR—coronary artery disease	2.52e-06	6.63e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GOT2—coronary artery disease	2.52e-06	6.63e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ALDH2—coronary artery disease	2.51e-06	6.6e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—HMGCR—coronary artery disease	2.5e-06	6.57e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GOT2—coronary artery disease	2.5e-06	6.57e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—APOA1—coronary artery disease	2.5e-06	6.56e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—APOA2—coronary artery disease	2.49e-06	6.55e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	2.49e-06	6.55e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GPX2—coronary artery disease	2.49e-06	6.55e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—KDR—coronary artery disease	2.47e-06	6.5e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—HK1—coronary artery disease	2.46e-06	6.47e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ABCG5—coronary artery disease	2.46e-06	6.47e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GPX4—coronary artery disease	2.46e-06	6.47e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—SULT1A1—coronary artery disease	2.46e-06	6.47e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PLCB1—coronary artery disease	2.46e-06	6.47e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MAPK14—coronary artery disease	2.46e-06	6.45e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	2.45e-06	6.44e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—HBA1—coronary artery disease	2.45e-06	6.43e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—LIPC—coronary artery disease	2.45e-06	6.43e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CYP2C19—coronary artery disease	2.45e-06	6.43e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PIK3C2A—coronary artery disease	2.45e-06	6.43e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—HADHA—coronary artery disease	2.43e-06	6.4e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—APOC3—coronary artery disease	2.43e-06	6.39e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—LDLR—coronary artery disease	2.42e-06	6.36e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	2.42e-06	6.35e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—ESR1—coronary artery disease	2.41e-06	6.33e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GSTA1—coronary artery disease	2.41e-06	6.32e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—SLC9A1—coronary artery disease	2.39e-06	6.28e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GSTT1—coronary artery disease	2.39e-06	6.28e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—ABCA1—coronary artery disease	2.39e-06	6.27e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GSTP1—coronary artery disease	2.38e-06	6.26e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—F2—coronary artery disease	2.38e-06	6.25e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—FN1—coronary artery disease	2.38e-06	6.25e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—LPA—coronary artery disease	2.38e-06	6.25e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IL6ST—coronary artery disease	2.37e-06	6.23e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CETP—coronary artery disease	2.36e-06	6.21e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GCLC—coronary artery disease	2.36e-06	6.21e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PPARGC1A—coronary artery disease	2.36e-06	6.2e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—NFKBIA—coronary artery disease	2.35e-06	6.18e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—HMOX1—coronary artery disease	2.35e-06	6.17e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—SDC1—coronary artery disease	2.34e-06	6.14e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PLCB1—coronary artery disease	2.32e-06	6.09e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CAT—coronary artery disease	2.32e-06	6.09e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GGT1—coronary artery disease	2.31e-06	6.07e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GOT1—coronary artery disease	2.31e-06	6.07e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PLCB3—coronary artery disease	2.3e-06	6.05e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PLCB1—coronary artery disease	2.3e-06	6.04e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—APOA5—coronary artery disease	2.28e-06	5.99e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—KIT—coronary artery disease	2.28e-06	5.99e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	2.26e-06	5.93e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—APOB—coronary artery disease	2.25e-06	5.91e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ABCA1—coronary artery disease	2.25e-06	5.91e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—P4HB—coronary artery disease	2.24e-06	5.88e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ABCA1—coronary artery disease	2.23e-06	5.86e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PSMB5—coronary artery disease	2.21e-06	5.8e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PSMA6—coronary artery disease	2.21e-06	5.8e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	2.2e-06	5.79e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	2.2e-06	5.77e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GSTM1—coronary artery disease	2.19e-06	5.75e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—GSK3B—coronary artery disease	2.19e-06	5.74e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GGT1—coronary artery disease	2.18e-06	5.72e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GOT1—coronary artery disease	2.18e-06	5.72e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—POMC—coronary artery disease	2.17e-06	5.7e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CREB1—coronary artery disease	2.17e-06	5.7e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GOT1—coronary artery disease	2.16e-06	5.67e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GGT1—coronary artery disease	2.16e-06	5.67e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CTGF—coronary artery disease	2.16e-06	5.67e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—LPL—coronary artery disease	2.15e-06	5.65e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GOT2—coronary artery disease	2.14e-06	5.61e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—HMGCR—coronary artery disease	2.14e-06	5.61e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CCL2—coronary artery disease	2.12e-06	5.57e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IL6R—coronary artery disease	2.12e-06	5.56e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GPX1—coronary artery disease	2.1e-06	5.51e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IGF1—coronary artery disease	2.09e-06	5.48e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—MAPK1—coronary artery disease	2.08e-06	5.45e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GSTP1—coronary artery disease	2.08e-06	5.45e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—VCAN—coronary artery disease	2.07e-06	5.44e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PPARGC1A—coronary artery disease	2.06e-06	5.4e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ALDOA—coronary artery disease	2.05e-06	5.4e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—HMOX1—coronary artery disease	2.05e-06	5.38e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CD36—coronary artery disease	2.04e-06	5.36e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CAT—coronary artery disease	2.02e-06	5.31e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PPP2CA—coronary artery disease	2.02e-06	5.3e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—DCN—coronary artery disease	1.99e-06	5.24e-05	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—PIK3CA—coronary artery disease	1.98e-06	5.21e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—SERPINE1—coronary artery disease	1.98e-06	5.2e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PLCB1—coronary artery disease	1.96e-06	5.16e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—APOB—coronary artery disease	1.96e-06	5.15e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GSTP1—coronary artery disease	1.96e-06	5.14e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ALDH2—coronary artery disease	1.94e-06	5.1e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GSTP1—coronary artery disease	1.94e-06	5.09e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	1.94e-06	5.09e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—MTHFR—coronary artery disease	1.93e-06	5.08e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—HMOX1—coronary artery disease	1.93e-06	5.07e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	1.93e-06	5.06e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	1.92e-06	5.05e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—FGF2—coronary artery disease	1.92e-06	5.04e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—HMOX1—coronary artery disease	1.91e-06	5.02e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GSTM1—coronary artery disease	1.91e-06	5.01e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ABCA1—coronary artery disease	1.9e-06	5e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CAT—coronary artery disease	1.9e-06	5e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—NOS3—coronary artery disease	1.89e-06	4.97e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—LIPC—coronary artery disease	1.89e-06	4.97e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—HBA1—coronary artery disease	1.89e-06	4.97e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CYP2C19—coronary artery disease	1.89e-06	4.97e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	1.89e-06	4.97e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CAT—coronary artery disease	1.89e-06	4.96e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—APOC3—coronary artery disease	1.88e-06	4.94e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—LPL—coronary artery disease	1.87e-06	4.92e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—LDLR—coronary artery disease	1.87e-06	4.91e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—APOB—coronary artery disease	1.85e-06	4.85e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GSTT1—coronary artery disease	1.84e-06	4.85e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—SLC9A1—coronary artery disease	1.84e-06	4.85e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GGT1—coronary artery disease	1.84e-06	4.85e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GOT1—coronary artery disease	1.84e-06	4.85e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—AGT—coronary artery disease	1.84e-06	4.83e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—JAK2—coronary artery disease	1.84e-06	4.83e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—APOB—coronary artery disease	1.83e-06	4.81e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GPX1—coronary artery disease	1.83e-06	4.8e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GCLC—coronary artery disease	1.82e-06	4.79e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CETP—coronary artery disease	1.82e-06	4.79e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—SDC1—coronary artery disease	1.8e-06	4.74e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—APOE—coronary artery disease	1.8e-06	4.73e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—PIK3CA—coronary artery disease	1.8e-06	4.73e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GSTM1—coronary artery disease	1.8e-06	4.72e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GSTM1—coronary artery disease	1.78e-06	4.68e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—APOA1—coronary artery disease	1.78e-06	4.68e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CD36—coronary artery disease	1.78e-06	4.67e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—LPL—coronary artery disease	1.76e-06	4.64e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PPP2CA—coronary artery disease	1.76e-06	4.62e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—LPL—coronary artery disease	1.75e-06	4.6e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GPX1—coronary artery disease	1.72e-06	4.52e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GPX1—coronary artery disease	1.71e-06	4.48e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.71e-06	4.48e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PSMA6—coronary artery disease	1.7e-06	4.48e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PSMB5—coronary artery disease	1.7e-06	4.48e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—MTHFR—coronary artery disease	1.69e-06	4.43e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CXCL8—coronary artery disease	1.68e-06	4.41e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CD36—coronary artery disease	1.68e-06	4.4e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CTGF—coronary artery disease	1.66e-06	4.37e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CD36—coronary artery disease	1.66e-06	4.37e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GSTP1—coronary artery disease	1.66e-06	4.35e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PPP2CA—coronary artery disease	1.66e-06	4.35e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—HMGCR—coronary artery disease	1.65e-06	4.33e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GOT2—coronary artery disease	1.65e-06	4.33e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	1.64e-06	4.31e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PPP2CA—coronary artery disease	1.64e-06	4.31e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—HMOX1—coronary artery disease	1.63e-06	4.29e-05	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—AKT1—coronary artery disease	1.62e-06	4.26e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CAT—coronary artery disease	1.61e-06	4.24e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CASP3—coronary artery disease	1.61e-06	4.22e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—AGT—coronary artery disease	1.6e-06	4.21e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—IL6—coronary artery disease	1.6e-06	4.19e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—MTHFR—coronary artery disease	1.59e-06	4.17e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—MTHFR—coronary artery disease	1.57e-06	4.14e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—APOE—coronary artery disease	1.57e-06	4.12e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PPARG—coronary artery disease	1.57e-06	4.12e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—APOB—coronary artery disease	1.57e-06	4.11e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CCND1—coronary artery disease	1.56e-06	4.11e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—APOA1—coronary artery disease	1.55e-06	4.08e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—POMC—coronary artery disease	1.55e-06	4.07e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GSTM1—coronary artery disease	1.52e-06	4e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MMP9—coronary artery disease	1.52e-06	3.99e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PLCB1—coronary artery disease	1.52e-06	3.98e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—AGT—coronary artery disease	1.51e-06	3.97e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—AGT—coronary artery disease	1.5e-06	3.93e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—LPL—coronary artery disease	1.49e-06	3.93e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—APOE—coronary artery disease	1.48e-06	3.89e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—AKT1—coronary artery disease	1.47e-06	3.87e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ABCA1—coronary artery disease	1.47e-06	3.86e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—APOE—coronary artery disease	1.47e-06	3.85e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—APOA1—coronary artery disease	1.46e-06	3.84e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GPX1—coronary artery disease	1.46e-06	3.83e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—APOA1—coronary artery disease	1.45e-06	3.81e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GOT1—coronary artery disease	1.42e-06	3.74e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GGT1—coronary artery disease	1.42e-06	3.74e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CD36—coronary artery disease	1.42e-06	3.73e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—ALB—coronary artery disease	1.41e-06	3.71e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PPP2CA—coronary artery disease	1.4e-06	3.68e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.39e-06	3.65e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PPARG—coronary artery disease	1.37e-06	3.59e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—VEGFA—coronary artery disease	1.36e-06	3.58e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—NOS3—coronary artery disease	1.35e-06	3.55e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—POMC—coronary artery disease	1.35e-06	3.54e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—MTHFR—coronary artery disease	1.35e-06	3.54e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PPARG—coronary artery disease	1.29e-06	3.38e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GSTP1—coronary artery disease	1.28e-06	3.36e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—AGT—coronary artery disease	1.28e-06	3.36e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PPARG—coronary artery disease	1.28e-06	3.36e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—POMC—coronary artery disease	1.27e-06	3.34e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	1.27e-06	3.33e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—HMOX1—coronary artery disease	1.26e-06	3.31e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—POMC—coronary artery disease	1.26e-06	3.31e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—APOE—coronary artery disease	1.25e-06	3.29e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—TGFB1—coronary artery disease	1.25e-06	3.29e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CAT—coronary artery disease	1.24e-06	3.27e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—APOA1—coronary artery disease	1.24e-06	3.25e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PTGS2—coronary artery disease	1.23e-06	3.24e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—ALB—coronary artery disease	1.23e-06	3.23e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MAPK1—coronary artery disease	1.23e-06	3.22e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—APOB—coronary artery disease	1.21e-06	3.17e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.19e-06	3.12e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—NOS3—coronary artery disease	1.18e-06	3.09e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GSTM1—coronary artery disease	1.18e-06	3.09e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ALB—coronary artery disease	1.16e-06	3.04e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—LPL—coronary artery disease	1.15e-06	3.03e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ALB—coronary artery disease	1.15e-06	3.02e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GPX1—coronary artery disease	1.13e-06	2.96e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—NOS3—coronary artery disease	1.11e-06	2.91e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—NOS3—coronary artery disease	1.1e-06	2.89e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CD36—coronary artery disease	1.1e-06	2.88e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PPARG—coronary artery disease	1.09e-06	2.87e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.08e-06	2.84e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—POMC—coronary artery disease	1.08e-06	2.83e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PTGS2—coronary artery disease	1.08e-06	2.83e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PIK3CA—coronary artery disease	1.06e-06	2.8e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.04e-06	2.73e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PTGS2—coronary artery disease	1.01e-06	2.66e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PTGS2—coronary artery disease	1e-06	2.64e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—AGT—coronary artery disease	9.87e-07	2.59e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ALB—coronary artery disease	9.81e-07	2.58e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—APOE—coronary artery disease	9.67e-07	2.54e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—APOA1—coronary artery disease	9.56e-07	2.51e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IL6—coronary artery disease	9.42e-07	2.48e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—NOS3—coronary artery disease	9.39e-07	2.47e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—AKT1—coronary artery disease	8.69e-07	2.28e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PTGS2—coronary artery disease	8.58e-07	2.26e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PPARG—coronary artery disease	8.42e-07	2.21e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—POMC—coronary artery disease	8.31e-07	2.18e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PIK3CA—coronary artery disease	7.59e-07	2e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ALB—coronary artery disease	7.57e-07	1.99e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—NOS3—coronary artery disease	7.24e-07	1.9e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PTGS2—coronary artery disease	6.62e-07	1.74e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PIK3CA—coronary artery disease	6.62e-07	1.74e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PIK3CA—coronary artery disease	6.23e-07	1.64e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—AKT1—coronary artery disease	6.2e-07	1.63e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PIK3CA—coronary artery disease	6.18e-07	1.62e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—AKT1—coronary artery disease	5.4e-07	1.42e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PIK3CA—coronary artery disease	5.28e-07	1.39e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—AKT1—coronary artery disease	5.09e-07	1.34e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—AKT1—coronary artery disease	5.05e-07	1.33e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—AKT1—coronary artery disease	4.31e-07	1.13e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PIK3CA—coronary artery disease	4.08e-07	1.07e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—AKT1—coronary artery disease	3.33e-07	8.75e-06	CbGpPWpGaD
